8-hydroxycudraxanthone G suppresses IL-8 production in SP-C1 tongue cancer cells

Insights

This study found that 8-hydroxycudraxanthone G, a compound from Garcinia mangostana, effectively suppresses interleukin-8 (IL-8) production in tongue cancer cells. This finding offers potential for new anti-cancer therapies targeting tumor angiogenesis.

Area of Science:

  • Pharmacology
  • Oncology
  • Natural Products Chemistry

Background:

  • Interleukin-8 (IL-8) production promotes tumor angiogenesis and disease progression in cancer.
  • Targeting IL-8 production represents a potential therapeutic strategy against cancer.

Purpose of the Study:

  • To investigate the potential of prenylated xanthones from Garcinia mangostana Linn (GML) to suppress IL-8 production in cancer cells.
  • To identify specific xanthone compounds with IL-8 inhibitory activity.

Main Methods:

  • Isolation of nine prenylated xanthones from GML pericarp.
  • Testing the ability of these xanthones to suppress IL-8 production in the SP-C1 tongue cancer cell line.
  • Quantification of IL-8 suppression by effective compounds.

Main Results:

  • 8-hydroxycudraxanthone G (compound 4) demonstrated significant suppression of IL-8 production.
  • Suppression of IL-8 was observed within 48 hours at a concentration of 15.7 microg/mL (45% reduction).
  • This is the first report detailing the IL-8 suppressive activity of 8-hydroxycudraxanthone G.

Conclusions:

  • 8-hydroxycudraxanthone G exhibits potent IL-8 suppressive activity in tongue cancer cells.
  • The prolonged suppression of IL-8 by 8-hydroxycudraxanthone G suggests its potential role in anti-cancer activity.
  • These findings highlight the therapeutic potential of GML-derived xanthones in targeting tumor angiogenesis.

Related Concept Videos